Alivas

Q: What is Alivas's official website?

Alivas's official website is www.alivas.co.jp

Q: What is Alivas's Revenue?

Alivas's revenue is <$5 Million

Q: What industry does Alivas belong to?

Alivas is in the industry of: Manufacturing , Medical Devices & Equipment

Q: What technology does Alivas use?

Some of the popular technologies that Alivas uses are: Sentry, F5 BIG-IP Platform, Sectigo, The USERTRUST Network

Q: How do I contact Alivas?

Alivas contact info: Phone number: +81 356159966 Website: www.alivas.co.jp

Q: What does Alivas do?

Alivas Inc. is a startup that develops innovative medical devices aimed at treating refractory chronic constipation, a condition affecting over 10 million people in Japan. The company emerged from the Japan Biodesign program, a collaboration between Stanford University and the University of Tokyo. Alivas is focused on providing new treatment option... s for patients who struggle with this challenging condition, particularly those unresponsive to drug therapies. Recently, the company secured approximately 350 million yen in Series B funding and was recognized as one of the top 20% of applicants in a major U.S. medical device acceleration program. Read More

Q: Is Alivas a public company?

Alivas is private company therefore does not currently have an official ticker symbol

Manufacturing · Japan · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Hongo, Tokyo, 113-0033, Japan

Phone Number

+81 356159966

Website

www.alivas.co.jp

Revenue

<$5 Million

Industry

Manufacturing

Medical Devices & Equipment

ZI Rank: 1

Signal Type

Jan

Feb

Mar

Apr

May

Jun

ZI Rank

About Alivas

Alivas Inc. is a startup that develops innovative medical devices aimed at treating refractory chronic constipation, a condition affecting over 10 million people in Japan. The company emerged from the Japan Biodesign program, a collaboration between Stanford University and the University of Tokyo. Alivas is focused on providing new treatment options for patients who struggle with this challenging condition, particularly those unresponsive to drug therapies. Recently, the company secured approximately 350 million yen in Series B funding and was recognized as one of the top 20% of applicants in a major U.S. medical device acceleration program.Explore more

Is this data correct?

View contact profiles from Alivas

Popular SearchesAlivas IncAlivasSIC Code 38,384NAICS Code 33,339Show more

Alivas Org Chart

Tomoyuki Tajima

Chief Executive Officer & Co-Founder

Phone

Pisit Kiatkittikul

Research Development Engineer & Manager, Qual...

Phone

Get the full picture

Is Alivas your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Click to see if Alivas had a recent Job posting/layoffs

Product Launch: Get notified when Alivas launches new products

Check out if Alivas is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Congratulate Masked Content for being promoted to Masked Content at Alivas

Alivas, which may be a good buyer, showed buying intent in Masked Content Topic

Funding: Get notified immidiatlly once Alivas has new funding data

Check if Alivas has recently received funding, and reach out quickly before it becomes old news!

Earning: See what the market has to say on Alivas recently announced quarterly report

Website visits: Recent activity has been detected on your website

Recommended Actions

Find VP level buyers at Alivas

Find more new buyers

View Email Formats for Alivas

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Alivas is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Alivas is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alivas.